DE69718911T2 - Interleukin - 8 als antivirale- und antitumorwirkstoffe - Google Patents

Interleukin - 8 als antivirale- und antitumorwirkstoffe

Info

Publication number
DE69718911T2
DE69718911T2 DE69718911T DE69718911T DE69718911T2 DE 69718911 T2 DE69718911 T2 DE 69718911T2 DE 69718911 T DE69718911 T DE 69718911T DE 69718911 T DE69718911 T DE 69718911T DE 69718911 T2 DE69718911 T2 DE 69718911T2
Authority
DE
Germany
Prior art keywords
interleukin
antituary
antiviral
active substances
caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69718911T
Other languages
English (en)
Other versions
DE69718911D1 (de
Inventor
Jean Gosselin
Pierre Borgeat
Bassam Damaj
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virocell Inc
Original Assignee
Virocell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virocell Inc filed Critical Virocell Inc
Application granted granted Critical
Publication of DE69718911D1 publication Critical patent/DE69718911D1/de
Publication of DE69718911T2 publication Critical patent/DE69718911T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2053—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/141—Interleukin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69718911T 1996-07-05 1997-07-04 Interleukin - 8 als antivirale- und antitumorwirkstoffe Expired - Fee Related DE69718911T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/674,633 US5900235A (en) 1996-07-05 1996-07-05 Interleukin-8 as an antiviral and antitumor agent
PCT/CA1997/000479 WO1998001150A1 (en) 1996-07-05 1997-07-04 Interleukin-8 as an antiviral and antitumor agent

Publications (2)

Publication Number Publication Date
DE69718911D1 DE69718911D1 (de) 2003-03-13
DE69718911T2 true DE69718911T2 (de) 2003-12-24

Family

ID=24707360

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69718911T Expired - Fee Related DE69718911T2 (de) 1996-07-05 1997-07-04 Interleukin - 8 als antivirale- und antitumorwirkstoffe

Country Status (12)

Country Link
US (1) US5900235A (de)
EP (1) EP0909178B1 (de)
JP (1) JP2000514066A (de)
KR (1) KR20000023562A (de)
AT (1) ATE232108T1 (de)
AU (1) AU713675B2 (de)
BR (1) BR9710206A (de)
CA (1) CA2258697A1 (de)
DE (1) DE69718911T2 (de)
ES (1) ES2191842T3 (de)
NZ (1) NZ333605A (de)
WO (1) WO1998001150A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962971B2 (en) * 2001-03-16 2005-11-08 The Regents Of The University Of California Chemokines and methods for inducing the differentiation of fibroblasts to myofibroblasts
AU2003287217B2 (en) 2002-10-24 2010-03-04 Paratek Pharmaceuticals, Inc. Methods of using substituted tetracycline compounds to modulate RNA
WO2005051405A1 (ja) * 2003-11-25 2005-06-09 Kaneka Corporation Ｉｌ－８産生促進剤とその用途
KR20230086610A (ko) 2021-12-07 2023-06-15 재단법인 아산사회복지재단 Il-12를 발현하는 재조합 백시니아 바이러스 및 이의 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3681795A (en) * 1994-09-23 1996-04-09 University Of Nebraska Board Of Regents Polypeptide agonists and antagonists of human interleukin-8

Also Published As

Publication number Publication date
ES2191842T3 (es) 2003-09-16
ATE232108T1 (de) 2003-02-15
BR9710206A (pt) 1999-08-10
AU3331497A (en) 1998-02-02
NZ333605A (en) 2000-12-22
AU713675B2 (en) 1999-12-09
CA2258697A1 (en) 1998-01-15
JP2000514066A (ja) 2000-10-24
DE69718911D1 (de) 2003-03-13
US5900235A (en) 1999-05-04
KR20000023562A (ko) 2000-04-25
EP0909178A1 (de) 1999-04-21
WO1998001150A1 (en) 1998-01-15
EP0909178B1 (de) 2003-02-05

Similar Documents

Publication Publication Date Title
OA08724A (fr) Treatment of human viral infections by dsRNA combined with viral inhibitors.
DK1027359T3 (da) Monocykliske L-nukleosider, analoger og anvendelser deraf
ATE303993T1 (de) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
ATE219366T1 (de) Verwendung von 5-fluoro-2'-deoxy-3'-thiacytidin zur behandlung von hepatitis b
ATE245641T1 (de) Antivirale pyrimidinderivate
EA199800733A1 (ru) Антагонисты рецептора il-8
ATE346651T1 (de) Nucleoside mit anti-hepatitis b virus wirksamkeit
EA200000911A1 (ru) Новые кристаллические формы антивирусного соединения бензимидазола
DK0973735T3 (da) Polyaromatiske antivirale præparater
ATE68349T1 (de) Medizinische verwendung von nukleosiden.
DE3872754T2 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
ES2123048T3 (es) Analogos de nucleosidos antiviricos.
EA199901024A1 (ru) Фармацевтическая антивирусная композиция, содержащая глицирризиновую кислоту и, по меньшей мере, один белок, обладающий антивирусной активностью
TR200401363T4 (tr) DNA viral enfeksiyonlarının tedavisi
EA199900843A1 (ru) Синтез 1,3-оксаселеноланнуклеозидов, их активность против вируса иммунодефицита человека и против вируса гепатита-b
ES2081286T3 (es) Nucleosidos de pirimidina antivirus del sida.
DE69718911D1 (de) Interleukin - 8 als antivirale- und antitumorwirkstoffe
MY124071A (en) Treatment of viral disease in swine
DE69004451T2 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
ES2162862T3 (es) Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
ATE112686T1 (de) Verwendungsmethoden von humanem gammainterferon 4-134.
ATE26267T1 (de) Pyrimidin-derivate, ausgestattet mit antiviraler wirkung.
BR0109345A (pt) Compostos com atividade anti-hiv
DE59100308D1 (de) Verwendung von s-adenosylmethionin als mittel gegen virale infektionen durch retroviren.
DE69210737D1 (de) Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee